EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Machine Learning-Based Multi-Class Prediction of Breast Cancer Tumor Stage Using Clinical and Pathological Features: A METABRIC Cohort Study

Muhammad Adeel Abid, Amna Siddique, Khadija Younas

International Journal of Innovations in Science and Technology · 27.09.2026 · 8 (7) · 3038

DOI: 10.33411/ijist/2046 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Innovations in Science and Technology, online erschienen am 27.09.2026. Verfasst von Muhammad Adeel Abid und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most frequently diagnosed cancer among women worldwide, and the tumor stage recorded at diagnosis strongly determines treatment planning, prognosis and survival. Unlike most prior METABRIC-based studies that predict molecular subtype or survival, this research benchmarks thirteen classifiers with four resampling strategies, hyperparameter optimization, cross-validation and SHAP-based explainability specifically for multi-class tumor-stage prediction from routinely collected clinical variables. Clinical and pathological records of 2,509 METABRIC patients are used, retaining 17 attributes and a four-level stage label. Stage 3 and 4 are merged into a single Advanced class to counter sparsity, and thirteen classifiers are trained on an 80:20 stratified split, compared against SMOTE, ADASYN, Borderline-SMOTE and random under sampling, then tuned via grid search and validated with 5-fold cross-validation. Random Forest with ADASYN gave the strongest pipeline, reaching 83.9% accuracy and macro-F1 of 0.770, versus 0.753 without resampling. The tuned model achieved a macro-AUC of 0.943, while a neural network underperformed the tree ensembles (macro-F1 = 0.75). SHAP identified positive lymph nodes, tumor size and the Nottingham Prognostic Index as the leading predictors, consistent with established clinical staging criteria. A resampled, tuned and explained ensemble model can support, but not replace, clinical tumor staging, pending further validation.

Zitieren

APA

Abid, M. A., Siddique, A., & Younas, K. (2026). Machine Learning-Based Multi-Class Prediction of Breast Cancer Tumor Stage Using Clinical and Pathological Features: A METABRIC Cohort Study. International Journal of Innovations in Science and Technology, 8(7), 3038. https://doi.org/10.33411/ijist/2046

Vancouver

Abid MA, Siddique A, Younas K. Machine Learning-Based Multi-Class Prediction of Breast Cancer Tumor Stage Using Clinical and Pathological Features: A METABRIC Cohort Study. International Journal of Innovations in Science and Technology. 2026;8(7):3038. doi:10.33411/ijist/2046

BibTeX
@article{Abid2026,
  author = {Abid, Muhammad Adeel and Siddique, Amna and Younas, Khadija},
  title = {Machine Learning-Based Multi-Class Prediction of Breast Cancer Tumor Stage Using Clinical and Pathological Features: A METABRIC Cohort Study},
  journal = {International Journal of Innovations in Science and Technology},
  year = {2026},
  volume = {8},
  number = {7},
  pages = {3038},
  doi = {10.33411/ijist/2046}
}
Kostenlos starten →